[Pulmonary embolism due to interaction between rivaroxaban and carbamazepine].

Abstract

We encourage monitoring of the anticoagulant effects of NOACs in case of drug-drug interactions, especially when NOACs are given in higher doses for a long period, in order to prevent treatment complications.